These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases. Lakatos G; Hritz I; Varga MZ; Juhász M; Miheller P; Cierny G; Tulassay Z; Herszényi L Dig Dis; 2012; 30(3):289-95. PubMed ID: 22722554 [TBL] [Abstract][Full Text] [Related]
3. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373 [TBL] [Abstract][Full Text] [Related]
4. Relationship between neutrophil gelatinase-associated lipocalin (NGAL) levels and inflammatory bowel disease type and activity. Yeşil A; Gönen C; Senateş E; Paker N; Gökden Y; Koçhan K; Erdem ED; Gündüz F Dig Dis Sci; 2013 Sep; 58(9):2587-93. PubMed ID: 23633156 [TBL] [Abstract][Full Text] [Related]
5. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity. Oikonomou KA; Kapsoritakis AN; Theodoridou C; Karangelis D; Germenis A; Stefanidis I; Potamianos SP J Gastroenterol; 2012 May; 47(5):519-30. PubMed ID: 22200942 [TBL] [Abstract][Full Text] [Related]
6. Assessment of IBD disease activity by Interleukin-6 and serum amyloid A in relation with fecal calprotectin and endoscopic indices. Bahaa A; Elbaz T; Elmakhzangy H; Shehata M; Abd El-Kareem D; Gaber A; Hashem MB; El Raziky M Arab J Gastroenterol; 2024 Aug; 25(3):299-305. PubMed ID: 39039004 [TBL] [Abstract][Full Text] [Related]
7. Serum ST2 in inflammatory bowel disease: a potential biomarker for disease activity. Boga S; Alkim H; Koksal AR; Ozagari AA; Bayram M; Tekin Neijmann S; Sen I; Alkim C J Investig Med; 2016 Jun; 64(5):1016-24. PubMed ID: 27001944 [TBL] [Abstract][Full Text] [Related]
8. Serum MMPs 7-9 and their inhibitors during glucocorticoid and anti-TNF-α therapy in pediatric inflammatory bowel disease. Mäkitalo L; Rintamäki H; Tervahartiala T; Sorsa T; Kolho KL Scand J Gastroenterol; 2012 Jul; 47(7):785-94. PubMed ID: 22519363 [TBL] [Abstract][Full Text] [Related]
9. Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania. Dumitrescu G; Mihai C; Dranga M; Prelipcean CC World J Gastroenterol; 2014 Mar; 20(9):2392-6. PubMed ID: 24605037 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Serum Calprotectin Levels in Patients with Inflammatory Bowel Disease. Mori A; Mitsuyama K; Sakemi R; Yoshioka S; Fukunaga S; Kuwaki K; Yamauchi R; Araki T; Yoshimura T; Yamasaki H; Tsuruta K; Morita T; Yamasaki S; Tsuruta O; Torimura T Kurume Med J; 2021 Dec; 66(4):209-215. PubMed ID: 34690210 [TBL] [Abstract][Full Text] [Related]
12. Serum adipokines in inflammatory bowel disease. Waluga M; Hartleb M; Boryczka G; Kukla M; Zwirska-Korczala K World J Gastroenterol; 2014 Jun; 20(22):6912-7. PubMed ID: 24944482 [TBL] [Abstract][Full Text] [Related]
13. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity. Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644 [TBL] [Abstract][Full Text] [Related]
14. Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease. Kovacs M; Papp M; Lakatos PL; Jacobsen S; Nemes E; Polgar M; Solyom E; Bodi P; Horvath A; Molnar K; Szabo D; Cseh A; Muller KE; Dezsofi A; Arato A; Veres G J Crohns Colitis; 2013 Mar; 7(2):134-41. PubMed ID: 22504031 [TBL] [Abstract][Full Text] [Related]
15. Growth differentiation factor-15 serum concentrations reflect disease severity and anemia in patients with inflammatory bowel disease. Tonkic A; Kumric M; Akrapovic Olic I; Rusic D; Zivkovic PM; Supe Domic D; Sundov Z; Males I; Bozic J World J Gastroenterol; 2024 Apr; 30(13):1899-1910. PubMed ID: 38659482 [TBL] [Abstract][Full Text] [Related]
16. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease. Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875 [TBL] [Abstract][Full Text] [Related]
17. α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease. Manolakis AC; Christodoulidis G; Kapsoritakis AN; Georgoulias P; Tiaka EK; Oikonomou K; Valotassiou VJ; Potamianos SP World J Gastroenterol; 2017 Jan; 23(3):437-446. PubMed ID: 28210079 [TBL] [Abstract][Full Text] [Related]